Skip to main content
. 2020 Jun 26;31(8):1859–1869. doi: 10.1681/ASN.2020010024

Table 1.

The ARIC-SHHS participant characteristics by OSA severity (n=1525)

Characteristics OSA Severity
Normal: AHI<5, n=776 Mild: AHI=5 to <15, n=452 Moderate: AHI=15 to <30, n=197 Severe: AHI≥30, n=100
Demographics
 Baseline age, yr, mean ± SD 61.7±5.4 63.2±5.2 63.3±5.4 63.1±5.1
 Women, n (%) 505 (65.1) 199 (44.0) 60 (30.5) 35 (35.0)
 Education level, n (%)
  Less than high school 69 (8.9) 54 (12.0) 27 (13.7) 9 (9.0)
  High school graduate 372 (47.9) 208 (46.0) 85 (43.1) 47 (47.0)
  More than high school graduate 335 (43.2) 190 (42.0) 85 (43.2) 44 (44.0)
Lifestyle behavioral characteristics
 Smoking, n (%)
  Current 107 (13.8) 31 (6.9) 16 (8.1) 9 (9.0)
  Former 340 (43.8) 239 (52.9) 106 (53.8) 54 (54.0)
  Never 329 (42.4) 182 (40.3) 75 (38.1) 37 (37.0)
 Alcohol consumption, n (%)
  Current 542 (69.9) 313 (69.3) 123 (62.4) 64 (64.0)
  Former 146 (18.8) 100 (22.1) 51 (25.9) 23 (23.0)
  Never 88 (11.3) 39 (8.6) 23 (11.7) 13 (13.0)
 Physical activity sport index, mean ± SD 2.7±0.8 2.7±0.8 2.6±0.7 2.4±0.7
Health status characteristics
 BMI, kg/m2, mean ± SD 27.0±4.3 29.1±4.8 31.1±5.5 33.8±5.5
 hsCRP, mg/L, mean ± SD 3.7±5.1 4.1±6.6 3.9±4.9 4.8±4.4
 Prevalent diabetes, n (%) 61 (7.9) 69 (15.3) 28 (14.2) 20 (20.0)
 Systolic BP, mm Hg, mean ± SD 123.3±17.0 127.7±18.6 126.2±17.6 130.1±16.9
 Diastolic BP, mm Hg, mean ± SD 69.7±9.1 71.5±9.8 71.3±9.1 73.4±10.2
 Antihypertensive medication use, n (%) 192 (24.7) 124 (27.4) 66 (33.5) 41 (41.0)
 Prevalent CHD, n (%) 56 (7.2) 34 (7.5) 25 (12.7) 9 (9.0)
 eGFR, ml/min per 1.73 m2, mean ± SD 90.4±13.6 89.5±15.3 88.3±13.2 85.5±13.3
Sleep characteristics
 Arousal index, average no. per night, mean ± SD 15.6±7.2 19.4±8.1 23.4±8.7 35.7±15.1
 Sleep efficiency, mean ± SD 85.0±8.6 83.5±9.3 82.2±9.4 81.8±10.8
 Self-reported poor sleep quality, n (%) 322 (41.5) 196 (43.4) 85 (43.1) 42 (42.0)
 Habitual sleep duration, average hours per night, mean ± SD 7.3±1.1 7.24±1.0 7.24±1.1 7.11±1.1

hsCRP, high-sensitivity C-reactive protein.